.RESEARCH HIGHLIGHT.06 August 2024.
A sizable randomized regulated test along with cisgender females highlights the difficulties of obedience to an everyday oral preexposure prevention program as well as demonstrates that twice-yearly shot of lenacapavir can maintain effective HIV avoidance degrees over 6 months.